Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population‐based study in Italy
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34923 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Luigino Dal Maso und 44 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Breast Neoplasms, Neoplasm Staging, Registries. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Health (Ricerca Corrente), Ministero della Salute.
Themen: Onkologische Pflege
Abstract (Originalsprache)
People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are increasing. This paper aimed to estimate the indicators of cancer cure and complete prevalence for Italian patients with BC and CRC by stage and age. A total of 31 Italian Cancer Registries (47% of the population) data until 2017 were included. Mixture cure models allowed estimation of net survival (NS); cure fraction (CF); time to cure (TTC, 5‐year conditional NS >95%); cure prevalence (who will not die of cancer); and already cured (prevalent patients living longer than TTC). 2.6% of all Italian women (806,410) were alive in 2018 after BC and 88% will not die of BC. For those diagnosed in 2010, CF was 73%, 99% when diagnosed at stage I, 81% at stage II, and 36% at stages III–IV. For all stages combined, TTC was >10 years under 45 and over 65 years and for women with advanced stages, but ≤1 year for all BC patients at stage I. The proportion of already cured prevalent BC women was 75% (94% at stage I). Prevalent CRC cases were 422,407 (0.7% of the Italian population), 90% will not die of CRC. For CRC patients, CF was 56%, 92% at stage I, 71% at stage II, and 35% at stages III–IV. TTC was ≤10 years for all age groups and stages. Already cured were 59% of all prevalent CRC patients (93% at stage I). Cancer cure indicators by stage may contribute to appropriate follow‐up in the years after diagnosis, thus avoiding patients' discrimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
- Epidemiological Department, Azienda Zero, Padua, Italy.
- National Centre for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
- Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.
- Registro Tumori ASL Napoli 3 Sud, Napoli, Italy.
- Tuscany Cancer Registry, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy.
ORCID-Profile: Luigino Dal Maso, Federica Toffolutti, Angela De Paoli, Fabiola Giudici, Silvia Francisci, Lauro Bucchi, Manuel Zorzi, Mario Fusco, Adele Caldarella, Silvia Rossi, Roberta De Angelis, Laura Botta, Alessandra Ravaioli, Antonino Musolino, Lucia Mangone, Enrica Migliore, Margherita Ferrante, Fabrizio Stracci, Rossella Cavallo, Walter Mazzucco, Paola Ballotari, Stefano Ferretti, Giuseppe Sampietro, Roberto Vito Rizzello, Lorenza Boschetti, Giuseppe Cascone, Michael Mian, Daniela Piras, Rocco Galasso, Pietro Seghini, Emanuele Crocetti, Diego Serraino, Stefano Guzzinati
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Italian Ministry of Health (Ricerca Corrente)
- Ministero della Salute
Zitieren
APA
Dal Maso, L., Toffolutti, F., De Paoli, A., Giudici, F., Francisci, S., Bucchi, L., Zorzi, M., Fusco, M., Caldarella, A., Rossi, S., De Angelis, R., Botta, L., Ravaioli, A., Casella, C., Musolino, A., Vitale, M. F., Mangone, L., Fanetti, A. C., Carpin, E., …, & AIRTUM Working Group (2024). Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population‐based study in Italy. International Journal of Cancer. https://doi.org/10.1002/ijc.34923
Vancouver
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, et al. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population‐based study in Italy. International Journal of Cancer. 2024. doi:10.1002/ijc.34923
BibTeX
@article{DalMaso2024,
author = {Dal Maso, Luigino and Toffolutti, Federica and De Paoli, Angela and Giudici, Fabiola and Francisci, Silvia and Bucchi, Lauro and Zorzi, Manuel and Fusco, Mario and Caldarella, Adele and Rossi, Silvia and De Angelis, Roberta and Botta, Laura and Ravaioli, Alessandra and Casella, Claudia and Musolino, Antonino and Vitale, Maria Francesca and Mangone, Lucia and Fanetti, Anna Clara and Carpin, Eva and Burgio Lo Monaco, Maria Giovanna and Migliore, Enrica and Gambino, Maria Letizia and Ferrante, Margherita and Stracci, Fabrizio and Gasparotti, Cinzia and Carrozzi, Giuliano and Cavallo, Rossella and Mazzucco, Walter and Ballotari, Paola and Ferretti, Stefano and Sampietro, Giuseppe and Rizzello, Roberto Vito and Boschetti, Lorenza and Cascone, Giuseppe and Mian, Michael and Pesce, Maria Teresa and Piras, Daniela and Galasso, Rocco and Bella, Francesca and Seghini, Pietro and Pinna, Pasquala and Crocetti, Emanuele and Serraino, Diego and Guzzinati, Stefano and AIRTUM Working Group, AIRTUM Working Group},
title = {Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population‐based study in Italy},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34923}
}
EUVIMED